Concepedia

Publication | Open Access

Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes

DOIFull Paper Access

133

Citations

29

References

2017

Year

Juraj Koska, Aramesh Saremi, Scott K. Howell, Gideon Bahn, Barbora de Courten, Henry N. Ginsberg, Paul J. Beisswenger, Peter D. Reaven
Diabetes Care

Abstract

Lower levels of MetSO and higher levels of select AGE are associated with increased incident CVD and may help account for the limited benefit of intensive glucose lowering in type 2 diabetes.

References

YearCitations

Page 1